
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PB | 999 | 63.2% | -1.40 | 379 | 84.4% |
| EB | 369 | 23.4% | -4.36 | 18 | 4.0% |
| CentralBrain-unspecified | 70 | 4.4% | -0.67 | 44 | 9.8% |
| GA(L) | 61 | 3.9% | -inf | 0 | 0.0% |
| CRE(L) | 48 | 3.0% | -2.78 | 7 | 1.6% |
| FB | 27 | 1.7% | -4.75 | 1 | 0.2% |
| ROB(L) | 6 | 0.4% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns EPGt | % In | CV |
|---|---|---|---|---|---|
| Delta7 (L) | 5 | Glu | 275.5 | 35.7% | 0.2 |
| P6-8P9 (R) | 2 | Glu | 103.5 | 13.4% | 0.1 |
| LPsP (L) | 1 | ACh | 47 | 6.1% | 0.0 |
| EPG (R) | 11 | ACh | 42 | 5.4% | 1.9 |
| LPsP (R) | 1 | ACh | 40.5 | 5.2% | 0.0 |
| ER3p_a (R) | 7 | GABA | 28.5 | 3.7% | 0.4 |
| ExR6 (L) | 1 | Glu | 20.5 | 2.7% | 0.0 |
| PEN_a(PEN1) (L) | 5 | ACh | 19.5 | 2.5% | 1.1 |
| PEN_b(PEN2) (L) | 1 | ACh | 19 | 2.5% | 0.0 |
| ER3p_a (L) | 6 | GABA | 16 | 2.1% | 0.5 |
| PEG (R) | 3 | ACh | 11.5 | 1.5% | 0.8 |
| EPGt (R) | 2 | ACh | 10.5 | 1.4% | 0.1 |
| OA-AL2i1 (R) | 1 | unc | 8.5 | 1.1% | 0.0 |
| EPG (L) | 2 | ACh | 8.5 | 1.1% | 0.2 |
| ExR6 (R) | 1 | Glu | 8 | 1.0% | 0.0 |
| PEN_b(PEN2) (R) | 3 | ACh | 7 | 0.9% | 0.7 |
| ER1_b (L) | 5 | GABA | 6.5 | 0.8% | 0.4 |
| ER1_b (R) | 5 | GABA | 6.5 | 0.8% | 0.6 |
| ExR1 (R) | 2 | ACh | 6 | 0.8% | 0.8 |
| ER1_a (R) | 5 | GABA | 6 | 0.8% | 0.4 |
| Delta7 (R) | 3 | Glu | 5.5 | 0.7% | 1.0 |
| PEN_a(PEN1) (R) | 4 | ACh | 5.5 | 0.7% | 0.9 |
| ER1_a (L) | 4 | GABA | 5.5 | 0.7% | 0.4 |
| IbSpsP (R) | 3 | ACh | 4.5 | 0.6% | 0.7 |
| ER3w_a (R) | 3 | GABA | 4.5 | 0.6% | 0.3 |
| ER3w_c (L) | 3 | GABA | 4 | 0.5% | 0.5 |
| hDeltaB (L) | 1 | ACh | 3.5 | 0.5% | 0.0 |
| ER3w_b (L) | 6 | GABA | 3.5 | 0.5% | 0.3 |
| PFNv (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| SMP371_a (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 3 | 0.4% | 0.0 |
| SpsP (R) | 1 | Glu | 2.5 | 0.3% | 0.0 |
| ExR4 (L) | 1 | Glu | 2.5 | 0.3% | 0.0 |
| ExR1 (L) | 2 | ACh | 2 | 0.3% | 0.5 |
| ExR7 (R) | 2 | ACh | 2 | 0.3% | 0.5 |
| PEG (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| EL (R) | 3 | OA | 2 | 0.3% | 0.4 |
| ExR7 (L) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| ER1_c (R) | 1 | GABA | 1.5 | 0.2% | 0.0 |
| ExR5 (R) | 2 | Glu | 1.5 | 0.2% | 0.3 |
| ExR4 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| ER3w_a (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| ER1_c (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| PS196_b (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| ExR2 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| EL (L) | 2 | OA | 1 | 0.1% | 0.0 |
| FB4Y (L) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| ER3w_c (R) | 2 | GABA | 1 | 0.1% | 0.0 |
| PLP046 (L) | 2 | Glu | 1 | 0.1% | 0.0 |
| PFGs (R) | 2 | unc | 1 | 0.1% | 0.0 |
| FC2A (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| hDeltaI (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FB5W_b (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| LAL206 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| FB4M (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| FB1H (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| ExR2 (R) | 1 | DA | 0.5 | 0.1% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 0.5 | 0.1% | 0.0 |
| vDeltaM (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FS2 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FS4B (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| FC1F (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| PFR_a (L) | 1 | unc | 0.5 | 0.1% | 0.0 |
| ExR5 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| PFR_b (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| ER3w_b (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| SIP136m (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| downstream partner | # | NT | conns EPGt | % Out | CV |
|---|---|---|---|---|---|
| Delta7 (R) | 18 | Glu | 112 | 15.1% | 0.6 |
| PFNd (R) | 2 | ACh | 97.5 | 13.2% | 0.0 |
| PEG (R) | 2 | ACh | 85 | 11.5% | 1.0 |
| Delta7 (L) | 15 | Glu | 66 | 8.9% | 0.6 |
| LPsP (L) | 1 | ACh | 42.5 | 5.7% | 0.0 |
| PFNa (R) | 3 | ACh | 37 | 5.0% | 0.1 |
| LPsP (R) | 1 | ACh | 35.5 | 4.8% | 0.0 |
| PEN_b(PEN2) (R) | 3 | ACh | 33 | 4.5% | 0.7 |
| IbSpsP (R) | 4 | ACh | 32.5 | 4.4% | 0.9 |
| PEN_a(PEN1) (R) | 1 | ACh | 21 | 2.8% | 0.0 |
| PFNv (R) | 1 | ACh | 20 | 2.7% | 0.0 |
| PFNp_c (R) | 2 | ACh | 19 | 2.6% | 0.0 |
| PFNp_a (R) | 5 | ACh | 13 | 1.8% | 0.8 |
| PFNp_b (R) | 7 | ACh | 12.5 | 1.7% | 0.5 |
| EPG (R) | 4 | ACh | 12 | 1.6% | 0.6 |
| EPGt (R) | 2 | ACh | 10.5 | 1.4% | 0.1 |
| ExR6 (L) | 1 | Glu | 9 | 1.2% | 0.0 |
| EL (R) | 4 | OA | 7.5 | 1.0% | 1.3 |
| PFNm_b (R) | 2 | ACh | 7 | 0.9% | 0.4 |
| PFNp_e (R) | 2 | ACh | 6.5 | 0.9% | 0.2 |
| FR1 (R) | 1 | ACh | 6 | 0.8% | 0.0 |
| PFGs (R) | 2 | unc | 5.5 | 0.7% | 0.6 |
| ExR6 (R) | 1 | Glu | 5 | 0.7% | 0.0 |
| PFNm_a (R) | 1 | ACh | 5 | 0.7% | 0.0 |
| ExR4 (L) | 1 | Glu | 4 | 0.5% | 0.0 |
| FC2A (R) | 1 | ACh | 3.5 | 0.5% | 0.0 |
| P6-8P9 (R) | 2 | Glu | 3.5 | 0.5% | 0.1 |
| ExR4 (R) | 1 | Glu | 3 | 0.4% | 0.0 |
| ER6 (L) | 2 | GABA | 3 | 0.4% | 0.0 |
| OA-AL2i1 (R) | 1 | unc | 2 | 0.3% | 0.0 |
| FR2 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| PEN_a(PEN1) (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| FC3_a (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| PEN_b(PEN2) (L) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| ExR1 (R) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| EPG (L) | 3 | ACh | 1.5 | 0.2% | 0.0 |
| FS3_c (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| FC2B (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| WEDPN5 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| FB4Y (R) | 2 | 5-HT | 1 | 0.1% | 0.0 |
| SpsP (R) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| ER1_b (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ExR8 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| EL (L) | 1 | OA | 0.5 | 0.1% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 0.5 | 0.1% | 0.0 |
| FS1A_a (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| CRE054 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ER1_b (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| GLNO (L) | 1 | unc | 0.5 | 0.1% | 0.0 |
| ER6 (R) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ExR2 (L) | 1 | DA | 0.5 | 0.1% | 0.0 |
| LAL100 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| ExR7 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |